Dermatology
Latest News
New Administration Routes for Adrenaline in Anaphylaxis
Intramuscular autoinjectors are not always used for a variety of reasons; new administration routes may increase use.
News
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
From the Journals
More evidence shows COVID-19’s link to risk for autoimmune disease
Patients with more severe COVID-19 that required hospitalization in the ICU were more likely to develop vasculitis, alopecia totalis, and several...
Latest News
Isothiazolinone contact allergy up in North America, down in Europe
The study compared the prevalence of positive patch test reactions to MCI/MI and to MI alone in North America and in Europe between 2009 and 2018...
Latest News
Manicure gone wrong leads to cancer diagnosis
She put antibiotic ointment on the cut, but it didn't heal after a few days. Eventually, the skin closed and a darkened bump formed.
Latest News
AAD unveils updated guidelines for topical AD treatment in adults
Of the 12 recommendations made for adults with AD, the work group ranked 7 as “strong” based on the evidence reviewed, and the rest as “...
Latest News
Topical psoriasis treatments
When using topical treatments, combination therapy is generally more effective than monotherapy for psoriasis, especially for plaque psoriasis, Dr...
From the Journals
New melting hydrogel bandage could treat burn wounds faster, with less pain
Bioengineers have created a new hydrogel formula that dissolves rapidly from wound sites.
Latest News
How to handle pesky molluscum contagiosum lesions
“If you don’t treat them, they’re going to spread,” Dr. Rebecca Smith said.
Feature
Breakthrough COVID studies lend support to use of new boosters in immunosuppressed patients
The findings of two studies underscore the importance of booster vaccine doses in those with immune-mediated inflammatory diseases who are taking...
News from the FDA/CDC
FDA approves dupilumab for treatment of prurigo nodularis
Approval was based on data from two randomized, controlled trials, PRIME and PRIME2, comparing dupilumab with placebo in 311 adults with...